Lawrence Rehabilitation Center to close amid market squeeze
The Lawrence Rehabilitation Center in Lawrence will close at month’s end after three years. rising competition from Mt Oread’s therapy units and anticipated cuts in Medicare and managed care reimbursements sparked the decision. Kansas Rehabilitation Hospital operates the center and will refer patients to other providers. the lease expires this month and the center has seen a steady patient decline.
MENTIONED IN THIS ARTICLE
Lawrence
Mt. Oread Medical Arts Centre
Columbia/HCA Corp
Gary Walker
Plaza Physical Therapy Services
Kansas Rehabilitation Hospital
Mt. Oread
Diana Malott
Kansas Rehabilitation
Malott
Gateway Dr
Lawrence Rehabilitation Center
Cindy Johnson
Therapyworks
W. Sixth
Johnson
FMC expands peroxide production in Texas
FMC Corp. announces a 65 million expansion at its Bayport Texas plant using new high efficiency technology. North American peroxide capacity will rise from 310 million to 450 million pounds annually, with products on the market by end of 1996. FMC expects hydrogen peroxide demand to grow at least 10 percent yearly.
MENTIONED IN THIS ARTICLE
FMC
Texas
FMC Corp
Bayport
Lawrence
Technology awards deadline nears for Kansas City entries
Nominations close Friday for the second annual Technology of the Year awards to be presented October 12 at the Doubletree Hotel in Overland Park. The Silicon Prairie Technology Association hosts the event with Campbell-Becker Inc. of Lawrence as sponsor.
MENTIONED IN THIS ARTICLE
Doubletree
Overland Park
Silicon Prairie Technology Assn
Campbell-Becker Inc
Lawrence
Kansas
Missouri
Kansas City
Upjohn and Pharmacia Merge to Form New Drug Giant
Upjohn Inc and Pharmacia AB announce a 13 billion dollar merger in a stock swap creating Pharmacia Upjohn Inc, the ninth largest global pharmaceutical maker. Pharmacia shareholders get one share per share, Upjohn holders receive 1.45 shares. Analysts note mixed investor expectations about payout versus growth potential.
MENTIONED IN THIS ARTICLE
Upjohn & Co
Sweden
Pharmacia AB
Pharmacia
Pharmacia & Upjohn Inc
Upjohn
Rodman & Renshaw
James Keeney
Upjohn and Pharmacia merge to form major global drugmaker
The merger aims to cut about 4000 jobs from a 34500 workforce and save 500 million annually by 1996. A 200 million restructuring charge is expected in 1995. The new firm, headquartered in London with offices in Stockholm, Milan, and Kalamazoo, will post 7 billion in sales and include Farmorubicin and Cleocin.
MENTIONED IN THIS ARTICLE
Upjohn and
Pharmacia
Pharmacia & Upjohn
Europe
North America
Japan
Upjohn
John Zabriskie
Zabriskie
Mutual funds face scrutiny over risk disclosure measures
The SEC weighs how to describe fund risk for investors amid industry pushback. Chair Arthur Levitt aims to simplify documents as analysts note current disclosures fail to convey risk. The Investment Company Institute presses for a 10 year bar chart of annual returns to show losses and gains.
MENTIONED IN THIS ARTICLE
Mutual Fund
Securities and Exchange Commission
Food and Drug Administration
SEC
Commission
Arthur Levitt Jr
Congress
Levitt
Investment Company Institute
Washington
Also Mentioned on This Page
Physical Therapy Center
Feds
Clinton
U.S
Medpartners
Medpartners Inc
Southeast
Midwest
Mullikin Medical Enterprises LP
Mullikin
Dilbert
Tim
Bloomberg Business News
Jayhawk Club
Tawnence Journal
Tom Jones
Aol
QUEEN
Windsong Luxury Royal Comfort
Cameo Imperial Luxury
Posture Superior
Mass
This is just the beginning! Our collection holds over 300 years of history, including rare newspapers, obituaries, marriage records, birth records, and so much more—most of which you won’t find anywhere else!